Usage of activating mutations in the analysis of cytokine signal transduction pathways

International Journal of Hematology

Volumn 67, Issue 3, 1998, Pages 221-227

  Onishi, Mayumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Activating mutations; Cytokine receptors; Gyrase; Retroviral expression cloning; Signal transduction

Indexed keywords

CYTOKINE RECEPTOR; DNA TOPOISOMERASE (ATP HYDROLYSING); ESTROGEN RECEPTOR;

EXPRESSION VECTOR; GENE EXPRESSION SYSTEM; GENE MUTATION; HUMAN; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032052561     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00009-7     Document Type: Review

References (21)

1. Mui A.L.-F., Wakao H., O'Farrell A., Harada N., Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J. 14:1995;1166-1175.
2. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science. 268:1995;251-255.
3. Ihle J.N. STATs: signal transducers and activators of transcription. Cell. 84:1996;331-334.
4. Schindler C., Darnell J. Jr. Transcriptional respones to polypeptide ligands; the JAK-STAT pathway. Annu. Rev. Biochem. 64:1995;621-651.
5. Watanabe S., Itoh T., Arai K. JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation throgh the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells. J Biol Chem. 271:1996;12681-12686.
6. Wen Z., Zhong Z., Darnell J. Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241-250.
7. Zhang X., Blenis J., Li H.C., Schindler C., Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science. 267:1995;1990-1994.
8. Gonda T.J., D'Andrea R. Activating mutations in cytokine receptors: implications for receptor function and role in disease. Blood. 89:1997;355-369.
9. Alexander W.S., Metcalf D., Dunn A.R. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J. 14:1995;5569-5578.
10. Jenkins B.J., D'Andrea R., Gonda T.J. Activating point mutations in the common β subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of β subunit dimerization and cell type-specific molecules in signalling. EMBO J. 14:1995;4276-4287.
11. Onishi M., Mui A.L.F., Morikawa Y., Cho L., Kinoshita S., Nolan G.P., Gorman D.M., Miyajima A., Kitamura T. Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer. Blood. 88:1996;1399-1406.
12. Kitamura T., Onishi M., Kinoshita S., Shibuya A., Miyajima A., Nolan G.P. Efficient screening of retroviral cDNA expression libraries. Proc Natl Acad Sci USA. 92:1995;9146-9150.
13. Onishi M., Kinoshita S., Morikawa Y.et al. Applications of retrovirus-mediated expression cloning. Exp Hematol. 24:1995;324-329.
14. Bergmann C.I., Hung M.-C., Weinberg R.A. Mutiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell. 45:1986;549-657.
15. Weiner D.B., Liu J., Cohen J.A., Williams W.V., Greene M.I. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature. 339:1989;230-231.
16. Farrar M.A., Alberola-lla J., Perlmutter R.M. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. Nature. 383:1996;178-181.
17. O'Farrell AM, Liu Y, Moore K, Mui AL-F. Interleukin 10 inhibits macrophage activation and proliferation by distinct signaling mechanism: Evidence of STAT3-dependent and independent pathways. EMBO J 1998;17:1006-18.
18. Samuels M.L., Weber M.J., Bishop J.M., McMahon M. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol. 13:1993;6241-6252.
19. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA. 90:1993;8392-8396.
20. Chu Y., Solski P.A., Khosravi-Far R., Der C.J., Kelly K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem. 271:1996;6497-6591.
21. Longmore G.D., Lordish H.F. An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: A cytokine receptor superfamily oncogene. Cell. 67:1991;1089-1102.